Hepion Pharmaceuticals Financials
| HEPADelisted Stock | USD 0.11 0.01 8.33% |
Hepion |
Understanding current and past Hepion Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hepion Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Hepion Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the presentation of Hepion Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hepion Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Hepion Pharmaceuticals' management manipulating its earnings.
Hepion Pharmaceuticals Stock Summary
Hepion Pharmaceuticals competes with ChampionX, Parker Hannifin, NETGEAR, Arrow Electronics, and RBC Bearings. Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Hepion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US4268971045 |
| CUSIP | 426897104 21234W103 426897302 21234W202 21234W400 426897401 |
| Location | New Jersey; U.S.A |
| Business Address | 55 Madison Avenue, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | hepionpharma.com |
| Phone | (732) 902 4000 |
| Currency | USD - US Dollar |
Hepion Pharmaceuticals Key Financial Ratios
Hepion Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hepion Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Hepion Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hepion Pharmaceuticals competition to find correlations between indicators driving Hepion Pharmaceuticals's intrinsic value. More Info.Hepion Pharmaceuticals is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hepion Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Hepion Pharmaceuticals Market Pulse
| Quote | 0.11 |
| Change(%) | 8.33 |
| Change | 0.01 |
| Open | 0.12 |
| Low | 0.11 |
| High | 0.14 |
| Volume | 0 |
| Exchange | NASDAQ |
About Hepion Pharmaceuticals Financials
What exactly are Hepion Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Hepion Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Hepion Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Hepion Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Hepion Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hepion Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Hepion Stock
If you are still planning to invest in Hepion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hepion Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |